Lovastatin in Treating Patients At High Risk of Melanoma

Clinical trial NCT00462280 · COMPLETED

Trial details

NCT number: NCT00462280
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Precancerous Condition Stage 0 Melanoma Stage I Melanoma Stage II Melanoma

Start date: 2007-05-01
Primary completion: 2011-04-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.